Submit your Manuscript
  • info@Jjgastro.com
Submit your Manuscript

Volume 2, Issue 12

Acetamiprid induced oxidative stress and genotoxicity in male albino rats: Attenuation by ambroxol

www.doi.org/10.52768/jjgastro/1104

The present study was undertaken to evaluate the oxidative stress and genotoxicity induced by 43.40 mg/kg/day of acetamiprid (ACE) in male rats and the protective role of 30 mg/kg/day of ambroxol (AMB) in male rats for consecutive 28 days. The results showed that the administration of ACE caused significant increments in the levels of catalase.

Tapping into ascites: Service evaluation of elective day-case paracentesis

www.doi.org/10.52768/jjgastro/1105

Ascites is the most common complication of liver cirrhosis. Large-volume paracentesis necessitates hospital admissions. Elective day-case paracentesis was introduced into Sandwell and West Birmingham NHS Trust in July 2019 to reduce inpatient bed occupancy. It was established under the condition of regular service review to ensure ongoing safety and cost savings.

An uncommon mediastinitis from infected pancreatic pseudocyst

www.doi.org/10.52768/jjgastro/1106

A 48-year-old man with a history of alcoholism and recurrent abdominal pain developed acute alcohol-induced pancreatitis and disruption of the main pancreatic duct with several intraabdominal noninfectious pancreatic pseudocysts. During the course of his hospitalization abdominal CT-scans showed a progression of one pseudocyst leading to an endoscopic cystogastrostomy 2 weeks later.

Determining the factors that predict the feasibility of one-stage primary esophageal repair versus staged repair in neonates with type C esophageal atresia: Developing some new criteria

www.doi.org/10.52768/jjgastro/1107

Several factors can predict the feasibility of primary repair or a staged repair should be done from the start in patients with esophageal atresia with distal tracheoesophageal fistula (Type C TEF) to avoid unnecessary lengthy operations which may result in high morbidity and mortality in such condition.

Is esomeprazole safe and effective in neonatal gastroesophageal reflux disease? A clinical trial

www.doi.org/10.52768/jjgastro/1108

Gastroesophageal reflux disease (GERD) is present in pediatric patients when reflux of gastric contents causes troublesome symptoms and/ or complications. GERD is one of the most common referrals to neonatal clinics. There are controversies in the pharmacologic treatment of GERD in neonates. There are very few studies that have compared the efficacy of esomeprazole with ranitidine in the management of neonatal GERD, so this study was performed.